Skip to main content
Auryxia 210 mg/1 tablet, film coated by Akebia Therapeutics, Inc.
Auryxia, 210 mg/1, tablet, film coated Drug class: Parenteral Iron Replacement; Phosphate Binder. Available on prescription only. Listed by Akebia Therapeutics, Inc..
Prescription only

Auryxia

ferric citrate

Listed by Akebia Therapeutics, Inc.

Strength
210 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Parenteral Iron Replacement; Phosphate Binder

What it contains

  • Tetraferric Tricitrate Decahydrate 210 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Parenteral Iron Replacement; Phosphate Binder
Approval route NDA — original brand approval
NDC code 59922-631
FDA application NDA205874
RxNorm concept 1594680
Package sizes listed 1
Marketed since September 2014

Other products containing Tetraferric Tricitrate Decahydrate

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Ferric Citrate

Strength
210 mg/1
Form
Tablet, Film Coated
Class
Parenteral Iron Replacement; Phosphate …
Rx only

Mylan Pharmaceuticals Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.